News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
873,343 Results
Type
Article (88181)
Company Profile (825)
Press Release (784316)
Multimedia
Podcasts (206)
Webinars (31)
Section
Business (233348)
Career Advice (4152)
Deals (39895)
Drug Delivery (156)
Drug Development (91477)
Employer Resources (205)
FDA (18438)
Job Trends (17440)
News (398127)
Policy (39996)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3023)
Academic (2)
Accelerated approval (41)
Adcomms (36)
Allergies (164)
Alliances (56982)
ALS (191)
Alzheimer's disease (1825)
Antibody-drug conjugate (ADC) (378)
Approvals (18639)
Artificial intelligence (682)
Autoimmune disease (197)
Automation (48)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (176)
Brain cancer (69)
Breast cancer (695)
Cancer (5339)
Cardiovascular disease (474)
Career advice (3578)
Career pathing (43)
CAR-T (318)
CDC (68)
Celiac Disease (2)
Cell therapy (877)
Cervical cancer (40)
Clinical research (77407)
Collaboration (1953)
Company closure (5)
Compensation (1232)
Complete response letters (82)
COVID-19 (3004)
CRISPR (110)
C-suite (967)
Cystic fibrosis (157)
Data (6685)
Decentralized trials (2)
Denatured (76)
Depression (162)
Diabetes (555)
Diagnostics (7325)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (329)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (258)
Earnings (100733)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135855)
Executive appointments (1071)
FDA (21809)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (26)
Funding (1640)
Gene editing (233)
Generative AI (71)
Gene therapy (719)
GLP-1 (1169)
Government (5482)
Grass and pollen (8)
Guidances (389)
Healthcare (20983)
HIV (76)
Huntington's disease (54)
IgA nephropathy (90)
Immunology and inflammation (310)
Immuno-oncology (75)
Indications (134)
Infectious disease (3321)
Inflammatory bowel disease (218)
Inflation Reduction Act (17)
Influenza (134)
Intellectual property (268)
Interviews (817)
IPO (17971)
IRA (61)
Job creations (5202)
Job search strategy (2867)
JPM (73)
Kidney cancer (20)
Labor market (98)
Layoffs (663)
Leadership (44)
Legal (10166)
Liver cancer (102)
Longevity (19)
Lung cancer (717)
Lymphoma (396)
Machine learning (49)
Management (66)
Manufacturing (921)
MASH (184)
Medical device (15093)
Medtech (15159)
Mergers & acquisitions (23044)
Metabolic disorders (1481)
mRNA (201)
Multiple sclerosis (179)
NASH (23)
Neurodegenerative disease (385)
Neuropsychiatric disorders (108)
Neuroscience (3246)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5122)
Now hiring (70)
Obesity (723)
Opinion (348)
Ovarian cancer (175)
Pain (230)
Pancreatic cancer (252)
Parkinson's disease (317)
Partnered (39)
Patents (546)
Patient recruitment (553)
Peanut (65)
People (67157)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23917)
Phase 2 (33586)
Phase 3 (25309)
Pipeline (6092)
Policy (358)
Postmarket research (3554)
Preclinical (10725)
Press Release (72)
Prostate cancer (273)
Psychedelics (60)
Radiopharmaceuticals (318)
Rare diseases (1018)
Real estate (7445)
Recruiting (81)
Regulatory (29353)
Reports (69)
Research institute (2744)
Resumes & cover letters (653)
Rett syndrome (31)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (278)
Series B (206)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4339)
State (2)
Stomach cancer (21)
Supply chain (117)
Tariffs (101)
The Weekly (128)
Vaccines (1192)
Venture capital (101)
Weight loss (495)
Women's health (105)
Worklife (23)
Date
Today (182)
Last 7 days (993)
Last 30 days (3218)
Last 365 days (32896)
2026 (5656)
2025 (33228)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (355)
Arkansas (15)
Asia (51695)
Australia (9084)
California (12195)
Canada (3469)
China (1232)
Colorado (514)
Connecticut (533)
Delaware (362)
Europe (118950)
Florida (1813)
Georgia (396)
Hawaii (4)
Idaho (68)
Illinois (1018)
India (81)
Indiana (574)
Iowa (24)
Japan (469)
Kansas (135)
Kentucky (48)
Louisiana (34)
Maine (84)
Maryland (1518)
Massachusetts (8950)
Michigan (381)
Minnesota (687)
Mississippi (7)
Missouri (145)
Montana (36)
Nebraska (30)
Nevada (134)
New Hampshire (88)
New Jersey (3277)
New Mexico (33)
New York (3216)
North Carolina (1686)
North Dakota (10)
Northern California (5899)
Ohio (377)
Oklahoma (23)
Oregon (55)
Pennsylvania (2428)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4724)
Tennessee (190)
Texas (1918)
United States (43895)
Utah (369)
Vermont (1)
Virginia (308)
Washington D.C. (88)
Washington State (1010)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
There are 873,343 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Chiesi Global Rare Diseases Announces FDA Approval of JUXTAPID® (lomitapide) Capsules for Pediatric Use in Homozygous Familial Hypercholesterolemia (HoFH)
March 3, 2026
·
11 min read
Press Releases
Cirrus Therapeutics Announces Strategic Expansion to Singapore and Other Key Updates Supporting its Growth as a Leading Global Ocular Immunology Company
March 3, 2026
·
4 min read
Press Releases
Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors
March 3, 2026
·
3 min read
Press Releases
Kyverna Therapeutics to Participate in Upcoming March 2026 Investor Conferences
March 3, 2026
·
1 min read
Press Releases
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
March 3, 2026
·
12 min read
Press Releases
Opus Genetics to Present at Upcoming Investor Conferences in March 2026
March 3, 2026
·
1 min read
Press Releases
Arcutis Begins Enrolling Phase 1a/1b Study Evaluating ARQ-234, a CD200R Agonist, in Healthy Volunteers and Adults With Atopic Dermatitis
March 3, 2026
·
6 min read
Press Releases
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
March 3, 2026
·
2 min read
Press Releases
Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
March 3, 2026
·
8 min read
Layoff Tracker
Cuts at Merck, Disc Leave Hundreds Jobless
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
March 3, 2026
·
60 min read
·
BioSpace Editorial Staff
1 of 87,335
Next
